Northwire Canada EditionMonday, July 13, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings

1933 Industries Announces Year End 2025 Financial Results and Reports Positive Income

TGIF · Price

Executive Summary

  • Reported audited FY 2025 results showing a swing to net income before tax of $0.03 M (vs. a loss of $2.25 M in FY 2024) and comprehensive income of $0.20 M.
  • Revenue of $17.45 M with record gross profit of $5.16 M and gross margin of 26% (up from 14%/15% in the prior year).
  • Closed a debenture repurchase agreement on Sep 9 2025, cancelling $475 k principal ($47.5 k cash) and saw expiration of stock options and warrants in Nov 2025.

Key Details

  • Financial Highlights FY 2025 vs. FY 2024
  • Revenue: $17,446,923 (down from $19,350,916).
  • Expenses: $5,131,128 (slightly lower than $5,196,048).
  • Gross profit: $5,164,676 vs. $2,941,963.
  • Gross margin (ex‑fair‑value): 26% vs. 14%; gross margin (incl. fair value): 30% vs. 15%.
  • Net income before tax: $33,548; comprehensive income: $197,621.
  • Prior year net loss before tax: $2,254,085; comprehensive loss: $1,065,679.

  • Operational Highlights

  • AMA brand ranked top‑5 cannabis seller in Nevada (overall) and top‑3 in concentrates for July, Sept, Oct 2025.
  • Improved THC concentrations in cultivated plants contributed to higher margins.

  • Subsequent Events

  • Debenture Repurchase Agreement (9 Sep 2025): repurchased $475,000 principal of unsecured convertible debentures; cash consideration $47,500; debentures cancelled and removed from liabilities.
  • Option/Warrant Expirations: 10,550,000 stock options (exercise $0.10) expired 8 Nov 2025; 3,700,000 share purchase warrants (exercise $0.08) expired 9 Nov 2025.

  • Regulatory/Market Context

  • Recent U.S. Farm Bill amendments redefining hemp THC limits may reduce competition from hemp‑derived products, potentially boosting demand for licensed cannabis in Nevada.

Notable Quotes

“Our performance in Fiscal 2025 reflects the strength of our strategy and the resilience of our team… Achieving positive income for the first time in the history of the Company gives us further confidence that we are on the right path.” – Brian Farrell, Chairman & CEO

“We are constantly innovating and remain agile in responding to changing market conditions… delivering value to our wholesale accounts.” – Ester Vigil, President

Read the original news release →

More from 1933 Industries Inc.